DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 76 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Beta Drugs Limited — Analysts/Institutional Investor Meet/Con. Call Updates

NSE 35 min ago·10 Sept 2026, 9:45 am

Beta Drugs

Beta Drugs Limited has announced the schedule for its upcoming analyst and institutional investor meet. The company will host a conference call to discuss its business performance and future outlook with market participants.

This event is significant for investors as it provides an opportunity to gain direct insights into the company's strategy and operational health from its management. Positive guidance or clarifications during the call could influence market sentiment and stock valuation.

Investors should closely monitor the company's prepared remarks and the Q&A session for any updates on sales, profitability, or upcoming projects. This information will be crucial for assessing the stock's near-term potential.